Pieces of the preeclampsia puzzle

Nephrology Dialysis Transplantation

Volumn 18, Issue 11, 2003, Pages 2209-2210

  Luft, Friedrich C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

ADMA; Angiotensin; Preeclampsia; VEGF

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

DRUG MECHANISM; EDITORIAL; ENDOTHELIUM LESION; ENZYME ACTIVATION; FEMALE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; MICROVASCULATURE; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PUERPERIUM; RAT; UTERINE ARTERY;

FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 0242320336     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg498     Document Type: Editorial

References (8)

1. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658
2. Luttun A, Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? J Clin Invest 2003; 111: 600-602
3. Dechend R, Viedt C, Muller DN et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003; 107: 1632-1639
4. Savvidou MD, Hingorani AD, Tsikas D, Fröhlich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet 2003; 361: 1511-1517
5. de Boer RA, Pinto YM, Suurmeijer AJ et al. Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. Cardiovasc Res 2003; 57: 434-442
6. Shimizu T, Okamoto H, Chiba S et al. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. Cardiovasc Res 2003; 58: 203-212
7. Delles C, Schneider MP, John S, Gekle M, Schmieder RE. Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens 2002; 15: 590-593
8. Page EL, Robitaille GA, Pouyssegur J, Richard DE. Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J Biol Chem 2002; 277: 48403-48409